NEW YORK, July 29 - Sequenom reported flat revenues for the second quarter today, amid narrowed net losses.
The San Diego company had revenues of $7.7 million for the quarter, compared to revenues of $7.7 million for the same period last year.
R&D expenses came to $6.5 million, compared to $8.1 million for the year-ago quarter.
The company's net loss narrowed to $9.3 million, from $15 million in the second quarter of 2002.
As of June 30, Sequenom had $82.9 million in cash, cash equivalents, short-term investments, and restricted cash.